Deutsche Bank Ag\ Fulcrum Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$262 Billion
Q2 2025

A detailed history of Deutsche Bank Ag\ transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 279,251 shares of FULC stock, worth $1.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

279,251

Previous 279,812 0.2%

Holding current value

$1.83 Million

Previous $805,000 138.63%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$2.51 - $7.38 $1,408 - $4,140	-561 Reduced 0.2%	279,251 $1.92 Million
Q1 2025 May 09, 2025	SELL	$2.88 - $5.08 $16,355 - $28,849	-5,679 Reduced 1.99%	279,812 $805,000
Q4 2024 Jun 30, 2025	BUY	$2.97 - $4.84 $16,866 - $27,486	5,679 Added 2.03%	285,491 $1.34 Million
Q4 2024 Feb 14, 2025	SELL	$2.97 - $4.84 $1,259 - $2,052	-424 Reduced 0.15%	285,491 $1.34 Million
Q3 2024 Jun 26, 2025	BUY	$3.18 - $9.74 $19,407 - $59,443	6,103 Added 2.18%	285,915 $1.02 Million
Q3 2024 Nov 13, 2024	SELL	$3.18 - $9.74 $1.79 Million - $5.49 Million	-563,278 Reduced 66.33%	285,915 $1.02 Million
Q2 2024 Jun 12, 2025	BUY	$5.98 - $9.31 $3.4 Million - $5.3 Million	569,381 Added 203.49%	849,193 $5.26 Million
Q2 2024 Aug 14, 2024	BUY	$5.98 - $9.31 $156,048 - $242,944	26,095 Added 3.17%	849,193 $5.26 Million
Q1 2024 Jun 02, 2025	BUY	$6.7 - $12.0 $3.64 Million - $6.52 Million	543,286 Added 194.16%	823,098 $7.77 Million
Q4 2023 Feb 14, 2024	BUY	$3.18 - $6.86 $2.62 Million - $5.65 Million	823,098 New	823,098 $5.56 Million
Q1 2023 May 15, 2023	BUY	$2.83 - $13.99 $36,690 - $181,380	12,965 Added 69.08%	31,733 $90,000
Q4 2022 Feb 13, 2023	SELL	$5.01 - $8.35 $24,859 - $41,432	-4,962 Reduced 20.91%	18,768 $136,000
Q3 2022 Nov 14, 2022	BUY	$4.92 - $9.1 $11,217 - $20,748	2,280 Added 10.63%	23,730 $192,000
Q2 2022 Aug 11, 2022	SELL	$4.2 - $24.0 $16,165 - $92,376	-3,849 Reduced 15.21%	21,450 $105,000
Q1 2022 May 13, 2022	SELL	$9.96 - $23.65 $20,796 - $49,381	-2,088 Reduced 7.62%	25,299 $598,000
Q4 2021 Feb 11, 2022	SELL	$14.0 - $28.44 $128,912 - $261,875	-9,208 Reduced 25.16%	27,387 $484,000
Q3 2021 Nov 04, 2021	BUY	$7.28 - $30.97 $170,679 - $726,091	23,445 Added 178.29%	36,595 $1.03 Million
Q2 2021 Aug 11, 2021	BUY	$8.09 - $12.0 $25,912 - $38,436	3,203 Added 32.2%	13,150 $138,000
Q1 2021 May 13, 2021	SELL	$10.94 - $15.32 $9,747 - $13,650	-891 Reduced 8.22%	9,947 $117,000
Q4 2020 Feb 16, 2021	BUY	$7.84 - $13.4 $23,606 - $40,347	3,011 Added 38.47%	10,838 $127,000
Q3 2020 Nov 12, 2020	BUY	$7.22 - $20.7 $10,230 - $29,331	1,417 Added 22.11%	7,827 $62,000
Q2 2020 Aug 13, 2020	BUY	$9.11 - $22.06 $16,161 - $39,134	1,774 Added 38.27%	6,410 $117,000
Q1 2020 May 14, 2020	BUY	$9.49 - $21.26 $29,665 - $66,458	3,126 Added 207.02%	4,636 $56,000
Q4 2019 Feb 14, 2020	BUY	$4.46 - $18.14 $1,378 - $5,605	309 Added 25.73%	1,510 $25,000
Q3 2019 Nov 14, 2019	BUY	$6.64 - $14.89 $7,974 - $17,882	1,201 New	1,201 $7,000

Others Institutions Holding FULC

# of Institutions

130

Shares Held

55.5M

Call Options Held

886K

Put Options Held

93.3K

View Full List

About Fulcrum Therapeutics, Inc.

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $340M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

More about FULC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account